Friday, February 22, 2013

• CURIS INC Files SEC form 8-K, Change in Directors or Principal Officers, Other Events, Financial Statements and ExhibEDGAR Online (Fri, Feb 22)

Thursday, February 21, 2013

• New Star Analyst Rankings for Curis, Inc.StarMine (Thu, Feb 21)

Wednesday, February 20, 2013

• Curis Management Discusses Q4 2012 Results - Earnings Call Transcriptat Seeking Alpha (Wed, Feb 20)
• CURIS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and ExhibitsEDGAR Online (Wed, Feb 20)
• Perry Ellis Expects Revenue Increase and 3 Stocks Hitting 52-Week Lowsat Wall St. Cheat Sheet (Wed, Feb 20)
• Q4 2012 Curis, Inc. Earnings Release - Before Market OpenCCBN (Wed, Feb 20)
• Curis Reports Fourth Quarter and Year-End 2012 Financial ResultsGlobeNewswire (Wed, Feb 20)

Tuesday, February 19, 2013

• ACT Biotech co-founder Ali Fattaey makes tracks to Curisat bizjournals.com (Tue, Feb 19)

Friday, January 18, 2013

• CURIS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and ExhibitsEDGAR Online (Fri, Jan 18)

Monday, December 24, 2012

• Biotech Portfolio Update: 2012 Summary And 2013 Outlookat Seeking Alpha (Mon, Dec 24)

Wednesday, December 12, 2012

• CURIS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Statements and ExhiEDGAR Online (Wed, Dec 12)

Monday, December 10, 2012

• 2 Biotech Firms With Significant Upside In The Wake Of Recent Developmentsat Seeking Alpha (Mon, Dec 10)

Thursday, December 6, 2012

• Curis Announces Patents and 1 Stock Dipping to 52-Week Lowsat Wall St. Cheat Sheet (Thu, Dec 6)
• Delcath Modifies Label, Curis Receives Patent: Healthcare Business Recapat Wall St. Cheat Sheet (Thu, Dec 6)

Wednesday, December 5, 2012

• Formation Of A New Expert Group Moves Pluristem Into The Expansive Hematology Fieldat Seeking Alpha (Wed, Dec 5)

Wednesday, November 28, 2012

• Pfizer Completes NextWave Purchase, Nymox Completes Patient Enrollment: Healthcare Business Recapat Wall St. Cheat Sheet (Wed, Nov 28)
• Genentech licenses early-stage cancer drug to Curisat bizjournals.com (Wed, Nov 28)
• CURIS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation oEDGAR Online (Wed, Nov 28)

Wednesday, November 14, 2012

• Republic Airways Initiated at Outperform and 4 Initiated Shares on the Moveat Wall St. Cheat Sheet (Wed, Nov 14)

Tuesday, November 6, 2012

• Curis' CEO Discusses Q3 2012 Results - Earnings Call Transcriptat Seeking Alpha (Tue, Nov 6)
• CURIS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and ExhibitsEDGAR Online (Tue, Nov 6)

Monday, October 22, 2012

• Curis: 4 Reasons To Consider This $4 Stockat Seeking Alpha (Mon, Oct 22)
• Curis: A Stock Fueled By Sonic Hedgehogat Seeking Alpha (Mon, Oct 22)

Thursday, September 27, 2012

• 4 Stocks Under $10 Making Big Movesat TheStreet (Thu, Sep 27)

Friday, September 14, 2012

• Emerging-Growth Opportunities in Oncology and Endocrinology Biotech: a Wall Street Transcript Interview with Boris Peaker of Oppenheimer & CompanyWall Street Transcript (Fri, Sep 14)

Add CRIS News to My Yahoo!